Brief
Early detection of disease is more likely to lead to a good outcome for patients and a cheaper, less complex solution for healthcare. Maxwell is using AI with both clinicians and consumers to find disease faster – to watch the body from the inside. They are starting with prostate cancer.
Investment
October 2017. Seed. Lead Partner: Phil Morle
Co-Investors
Brisbane Development Fund, RCL Accelerator/Muru-D
Website
